Related Experiment Video
Updated: Jun 13, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease
Benjamin Sadowitz1, Kristopher G Maier, Vivian Gahtan
1Division of Vascular Surgery and Endovascular Services, SUNY Upstate Medical University, Syracuse, NY, USA.
Insights
Statins, or HMG CoA-reductase inhibitors, treat high cholesterol and reduce cardiovascular risks. Beyond lowering cholesterol, they offer cellular benefits like reduced inflammation and plaque stabilization.
Area of Science:
- Cardiovascular Pharmacology
- Cellular Biology
- Biochemistry
Background:
- Hypercholesterolemia is a primary risk factor for cardiovascular diseases.
- Statins (HMG CoA-reductase inhibitors) are the leading treatment for hypercholesterolemia.
- Statin therapy significantly reduces cardiovascular morbidity and mortality.
Purpose of the Study:
- To review the pleiotropic effects of statins at the cellular level.
- To explore mechanisms beyond cholesterol reduction.
- To provide foundational knowledge for Part II of the review.
Main Methods:
- Literature review of studies on statin mechanisms.
- Analysis of cellular and molecular effects of statins.
- Synthesis of data on pleiotropic actions.
Main Results:
- Statins exhibit cholesterol-independent "pleiotropic" effects.
- These effects include reduced vascular inflammation.
- Improved endothelial function, plaque stabilization, and inhibited cell migration/proliferation were noted.
Conclusions:
- Statins provide cardiovascular benefits through both cholesterol reduction and pleiotropic actions.
- Cellular-level pleiotropic effects contribute significantly to cardiovascular protection.
- Understanding these cellular effects is crucial for optimizing statin therapy.
Abstract:
3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG CoA-reductase) inhibitors, otherwise known as statins, are currently the medical treatment of choice for hypercholesterolemia. Hypercholesterolemia is a known risk factor for cardiovascular disease, and statin therapy has led to a significant reduction in morbidity and mortality from adverse cardiac events, stroke, and peripheral arterial disease. In addition to achieving a therapeutic decrease in serum cholesterol levels, statin therapy appears to promote other effects that are independent of changes in serum cholesterol. These ''pleiotropic'' effects include attenuation of vascular inflammation, improved endothelial cell function, stabilization of atherosclerotic plaque, decreased vascular smooth muscle cell migration and proliferation, and inhibition of platelet aggregation. This article is part I of a 2-part review, and it focuses on the pleiotropic effects of statins at the cellular level.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis I: Introduction
Coronary Artery Disease V: Interprofessional Care